Skip to main content

Table 1 Proportion of seropositivity for antibodies against LID-1, NDO-LID, NDO-HSA and PGL-1 according to groups of individuals

From: Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region

   No. (%) positivea
No. of samples LID-1 NDO-LID NDO-HSA PGL-1
Patients MB 43 34(89.5) 38(71.7) 33(76.7) 38(66.7)
  PB 51 4(10.5) 15(28.3) 10(23.3) 19(33.3)
HHC MBb 81 35(43.2) 31(38.3) 10(12.3) 14(17.3)
PBc 23 6(26.1) 6(26.1) 0(0.0) 1(4.3)
GPop   2494 74(21.9) 995(41.2) 191(7.9) -
  1. aTest were considered positive when a distinct band was observed (scored as EI of 1.1 or greater)
  2. bHHC of patients classified as MB
  3. cHHC of patients classified as PB